These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3332085)

  • 1. The myelodysplastic syndromes.
    Verwilghen RL; Boogaerts MA
    Blood Rev; 1987 Mar; 1(1):34-43. PubMed ID: 3332085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, classification, and course of myelodysplastic syndromes.
    McKenna RW; Allison PM
    Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndromes.
    Adès L; Itzykson R; Fenaux P
    Lancet; 2014 Jun; 383(9936):2239-52. PubMed ID: 24656536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic Syndromes: Updates and Nuances.
    Dao KT
    Med Clin North Am; 2017 Mar; 101(2):333-350. PubMed ID: 28189174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
    Platzbecker U; Wong RS; Verma A; Abboud C; Araujo S; Chiou TJ; Feigert J; Yeh SP; Götze K; Gorin NC; Greenberg P; Kambhampati S; Kim YJ; Lee JH; Lyons R; Ruggeri M; Santini V; Cheng G; Jang JH; Chen CY; Johnson B; Bennett J; Mannino F; Kamel YM; Stone N; Dougherty S; Chan G; Giagounidis A
    Lancet Haematol; 2015 Oct; 2(10):e417-26. PubMed ID: 26686043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndromes or refractory anemias].
    Fenaux P
    Rev Prat; 1993 Jun; 43(11):1379-85. PubMed ID: 8235387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia.
    Yoshida Y; Stephenson J; Mufti GJ
    Int J Hematol; 1993 Apr; 57(2):87-97. PubMed ID: 8494998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal studies after bone marrow transplantation for leukaemia in children.
    van den Berg H; Beverstock G; Westerhof JP; Vossen JM
    Bone Marrow Transplant; 1991 May; 7(5):335-42. PubMed ID: 2070142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome.
    Warny M; Helby J; Sengeløv H; Nordestgaard BG; Birgens H; Bojesen SE
    Eur J Haematol; 2019 Mar; 102(3):218-226. PubMed ID: 30427547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preleukaemia and myelodysplastic syndromes today.
    Jacobs A
    Recenti Prog Med; 1989 Oct; 80(10):501-7. PubMed ID: 2690216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
    Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
    Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndromes--pathogenesis and treatment].
    Homenda W; Pejska M; Kochanowska-Demczyna A
    Wiad Lek; 2005; 58(3-4):204-7. PubMed ID: 16119165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
    Garcia-Manero G
    Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to treat myelodysplastic syndromes.
    Akhtari M
    Oncology (Williston Park); 2011 May; 25(6):480-6. PubMed ID: 21717901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
    Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndromes.
    Doll DC; List AF
    West J Med; 1989 Aug; 151(2):161-7. PubMed ID: 2672599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study.
    DiNardo CD; Daver N; Jabbour E; Kadia T; Borthakur G; Konopleva M; Pemmaraju N; Yang H; Pierce S; Wierda W; Bueso-Ramos C; Patel KP; Cortes JE; Ravandi F; Kantarjian HM; Garcia-Manero G
    Lancet Haematol; 2015 Jan; 2(1):e12-20. PubMed ID: 26687423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and therapy strategy in myelodysplastic syndromes].
    Gattermann N; Aul C
    Praxis (Bern 1994); 1996 Jan; 85(3):39-44. PubMed ID: 8578048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.